immunAware ApS: Financial statements 2019
CVR: 39189135
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
immunAware ApS (CVR 39189135) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,283,575 and a net result of DKK 1,388,135 compared with DKK 18,735 the year before. That is an increase of 9,040.5% compared with the year before. Equity in the 2019 report amounted to DKK 1,539,370. The solvency ratio was 76.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 2,283,575
- Profit/Loss
- DKK 1,388,135
- Equity
- DKK 1,539,370
- Total Assets
- DKK 2,018,159
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.3 mio. | 1.4 mio. | 1.5 mio. | 1 |
| 2018 | - | 25 t. | 19 t. | 151 t. | 0 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ImmunAware ApS has published its annual report for 2018. Gross profit came to DKK 24,983, and the net result was DKK 18,735.
About immunAware ApS
immunAware ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Søren Buus, Anette Stryhn Buus and Thomas Østerbye. The company is owned by PROSAL ApS, ASTIM Holding ApS and T.Ø. Holding ApS. In 2025, the company reported a gross profit of DKK 4,626,954 and a net result of DKK -338,581 compared with DKK -757,428 the year before. Equity in the 2025 report amounted to DKK 4,913,587.